Literature DB >> 11139282

Ectopic expression of Bcl-2 switches over nuclear signalling for cAMP-induced apoptosis to granulocytic differentiation.

P Séité1, S Ruchaud, J Hillion, M C Gendron, O Bruland, E Ségal-Bendirdjian, S O Doskeland, J R Lillehaug, M Lanotte.   

Abstract

The IPC-81 myeloid leukaemia cells undergo apoptosis rapidly after cAMP stimulation (6 h) and cell death is prevented by early over-expression of the cAMP-inducible transcription repressor ICER, that blocks cAMP-dependent nuclear signalling. Therefore, the expression of specific genes controlled by CRE-containing promoters is likely to determine cell fate. We now show that cAMP-induced cell death also is abrogated by the over-expression of the anti-apoptotic gene, Bcl-2. Contrary to ICER, Bcl-2 does not affect cAMP-signalling and allows the analysis of cAMP responses in death rescued cells. The Bcl-2 transfected cells treated with 8-CPT-cAMP were growth-arrested and thereafter cells embarked in granulocytic differentiation, with no additional stimulation. Neutrophilic polynuclear granulocytes benefited from a long life span in G0-G1 and remained functional (phagocytosis). This work demonstrates that, using anti-apoptosis regulators, 'death signals' could be exploited to trigger distinct biological responses. Indeed, cAMP signal can trigger several simultaneously developing biological programs, in the same cell, i.e., growth regulation, apoptosis and differentiation. This cell system should prove useful to determine how a tumour cell can be re-programmed for either apoptosis or functional maturation by physiological signals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11139282     DOI: 10.1038/sj.cdd.4400730

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  7 in total

Review 1.  Differentiation, apoptosis, and function of human immature and mature myeloid cells: intracellular signaling mechanism.

Authors:  Akira Yuo
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

2.  Marine benthic cyanobacteria contain apoptosis-inducing activity synergizing with daunorubicin to kill leukemia cells, but not cardiomyocytes.

Authors:  Linn Oftedal; Frode Selheim; Matti Wahlsten; Kaarina Sivonen; Stein Ove Døskeland; Lars Herfindal
Journal:  Mar Drugs       Date:  2010-10-14       Impact factor: 5.118

3.  Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription.

Authors:  S Huseby; G Gausdal; T J Keen; E Kjærland; C Krakstad; L Myhren; K Brønstad; C Kunick; F Schwede; H-G Genieser; R Kleppe; S O Døskeland
Journal:  Cell Death Dis       Date:  2011-12-08       Impact factor: 8.469

4.  Marine benthic diatoms contain compounds able to induce leukemia cell death and modulate blood platelet activity.

Authors:  Siv Kristin Prestegard; Linn Oftedal; Rosie Theresa Coyne; Gyrid Nygaard; Kaja Helvik Skjaerven; Gjert Knutsen; Stein Ove Døskeland; Lars Herfindal
Journal:  Mar Drugs       Date:  2009-11-18       Impact factor: 5.118

5.  Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines.

Authors:  Therese Bredholt; Elizabeth Ao Dimba; Hanne R Hagland; Line Wergeland; Jørn Skavland; Kjell O Fossan; Karl J Tronstad; Anne C Johannessen; Olav K Vintermyr; Bjørn T Gjertsen
Journal:  Mol Cancer       Date:  2009-11-13       Impact factor: 27.401

6.  Iodinin (1,6-dihydroxyphenazine 5,10-dioxide) from Streptosporangium sp. induces apoptosis selectively in myeloid leukemia cell lines and patient cells.

Authors:  Lene E Myhren; Gyrid Nygaard; Gro Gausdal; Håvard Sletta; Knut Teigen; Kristin F Degnes; Kolbjørn Zahlsen; Anders Brunsvik; Øystein Bruserud; Stein Ove Døskeland; Frode Selheim; Lars Herfindal
Journal:  Mar Drugs       Date:  2013-01-30       Impact factor: 5.118

7.  Cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells.

Authors:  Liwei Liu; Lars Herfindal; Jouni Jokela; Tania Keiko Shishido; Matti Wahlsten; Stein Ove Døskeland; Kaarina Sivonen
Journal:  Mar Drugs       Date:  2014-04-03       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.